Logo image of ALCWE.PA

CHARWOOD ENERGY SA (ALCWE.PA) Stock Fundamental Analysis

EPA:ALCWE - Euronext Paris - Matif - FR001400AJ60 - Common Stock - Currency: EUR

2.92  -0.06 (-2.01%)

Fundamental Rating

3

ALCWE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. While ALCWE seems to be doing ok healthwise, there are quite some concerns on its profitability. ALCWE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALCWE has reported negative net income.
ALCWE had a negative operating cash flow in the past year.
In the past 5 years ALCWE reported 4 times negative net income.
In the past 5 years ALCWE reported 4 times negative operating cash flow.
ALCWE.PA Yearly Net Income VS EBIT VS OCF VS FCFALCWE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -1M -2M -3M -4M

1.2 Ratios

Industry RankSector Rank
ROA -31.76%
ROE -68.66%
ROIC N/A
ROA(3y)-15.48%
ROA(5y)-7.36%
ROE(3y)-30.7%
ROE(5y)-10.92%
ROIC(3y)N/A
ROIC(5y)N/A
ALCWE.PA Yearly ROA, ROE, ROICALCWE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

ALCWE's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for ALCWE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 110.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.8%
GM growth 5YN/A
ALCWE.PA Yearly Profit, Operating, Gross MarginsALCWE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 50 -50 100

More info and screens

4

2. Health

2.1 Basic Checks

ALCWE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALCWE has more shares outstanding
Compared to 1 year ago, ALCWE has a worse debt to assets ratio.
ALCWE.PA Yearly Shares OutstandingALCWE.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
ALCWE.PA Yearly Total Debt VS Total AssetsALCWE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5M 10M

2.2 Solvency

Based on the Altman-Z score of 0.68, we must say that ALCWE is in the distress zone and has some risk of bankruptcy.
ALCWE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.68
ROIC/WACCN/A
WACC8.28%
ALCWE.PA Yearly LT Debt VS Equity VS FCFALCWE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

A Current Ratio of 1.62 indicates that ALCWE should not have too much problems paying its short term obligations.
A Quick Ratio of 1.19 indicates that ALCWE should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 1.19
ALCWE.PA Yearly Current Assets VS Current LiabilitesALCWE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

6

3. Growth

3.1 Past

ALCWE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -123.61%.
The Revenue has grown by 23.58% in the past year. This is a very strong growth!
ALCWE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.52% yearly.
EPS 1Y (TTM)-123.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-178.9%
Revenue 1Y (TTM)23.58%
Revenue growth 3Y3.52%
Revenue growth 5YN/A
Sales Q2Q%3.95%

3.2 Future

ALCWE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 74.80% yearly.
The Revenue is expected to grow by 109.12% on average over the next years. This is a very strong growth
EPS Next Y61.11%
EPS Next 2Y74.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year70.91%
Revenue Next 2Y116.59%
Revenue Next 3Y109.12%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALCWE.PA Yearly Revenue VS EstimatesALCWE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
ALCWE.PA Yearly EPS VS EstimatesALCWE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2024 2025 2026 0 0.1 -0.1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALCWE. In the last year negative earnings were reported.
Also next year ALCWE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALCWE.PA Price Earnings VS Forward Price EarningsALCWE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALCWE.PA Per share dataALCWE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

ALCWE's earnings are expected to grow with 74.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y74.8%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALCWE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHARWOOD ENERGY SA

EPA:ALCWE (7/18/2025, 7:00:00 PM)

2.92

-0.06 (-2.01%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap15.24M
Analysts86.67
Price Target5.61 (92.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.01
P/FCF N/A
P/OCF N/A
P/B 2.99
P/tB 3.99
EV/EBITDA N/A
EPS(TTM)-0.67
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)-0.38
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS0.97
BVpS0.98
TBVpS0.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -31.76%
ROE -68.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 110.94%
FCFM N/A
ROA(3y)-15.48%
ROA(5y)-7.36%
ROE(3y)-30.7%
ROE(5y)-10.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.8%
GM growth 5YN/A
F-Score4
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 84.78%
Cap/Sales 10.97%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.62
Quick Ratio 1.19
Altman-Z 0.68
F-Score4
WACC8.28%
ROIC/WACCN/A
Cap/Depr(3y)311.15%
Cap/Depr(5y)252.07%
Cap/Sales(3y)27.68%
Cap/Sales(5y)18.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-123.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-178.9%
EPS Next Y61.11%
EPS Next 2Y74.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.58%
Revenue growth 3Y3.52%
Revenue growth 5YN/A
Sales Q2Q%3.95%
Revenue Next Year70.91%
Revenue Next 2Y116.59%
Revenue Next 3Y109.12%
Revenue Next 5YN/A
EBIT growth 1Y-64.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year100%
EBIT Next 3Y50.37%
EBIT Next 5YN/A
FCF growth 1Y52.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y36.82%
OCF growth 3YN/A
OCF growth 5YN/A